Wockhardt cash flow

Latest FY26
Cash from operations
₹390cr−₹22.0 cr in FY25
Capital spending
₹136cr+44.7% on FY25
Free cash flow
₹254cr−₹116 cr in FY25
Cash from financing
−₹54.0cr₹409 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—227217223251
—0.00.079.033.0
—213254305302
—−5.0−16.0−6.0−4.0
—−13.0−7.00.00.0
—4.01.01.01.0
—1.04.0−2.0−80.0
—28.02.077.0132
Changes in working capital
—−112−69.08.0141
—21.0−66.0142199
—29.0−19235.018.0
—−220−165−193−205
Cash from operating activities
463238−16.0−420−624
—173−37.0669788
—411−53.0249164
—21.0−31.030.011.0
—390−22.0219153
Cash from investing activities
—13694.059.042.0
—50.010.066.079.0
—2282710.00.0
—0.00.0−157−167
—−39.04040.00.0
—5.016.03.02.0
—29.0−40.010.03.0
—−241−783−137−125
Cash from financing activities
—0.0982467−3.0
—737728549409
—5251,067406406
—71.070.079.073.0
—−195−164−197−242
—−54.0409334−315
—95.0−396416−287
—10.03.0−1.07.0
—105−393415−280
———50590.0
Reference items
77265239339.0101
21.7%19.3%13.1%1.4%3.8%
254254−116160111
₹15.68₹15.68−₹7.16₹9.88₹6.85
122.64×————
—1.96×0.39×−0.46×−0.25×
—21.0−31.030.011.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

WOCKPHARMA₹1,922.90

Wockhardt Ltd.

· Pharma & Health
₹ CrorePeersBIOCONSYNGENEASTERDMGLANDPPLPHARMACOHANCELALPATHLABNATCOPHARMMcap ₹31,151 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation251.0223.0217.0227.0—
+ Impairment Loss / (Reversal)33.079.00.00.0—
+ Finance Costs302.0305.0254.0213.0—
+ Interest Income-4.0-6.0-16.0-5.0—
+ Fair Value (Gains) / Losses0.00.0-7.0-13.0—
+ Share-based Payments1.01.01.04.0—
+ Unrealised FX (Gain) / Loss-80.0-2.04.01.0—
+ Other Non-cash Items132.077.02.028.0—
Changes in Working Capital
+ Inventories141.08.0-69.0-112.0—
+ Trade Receivables — Current199.0142.0-66.021.0—
+ Other Current Assets18.035.0-192.029.0—
+ Other Current Liabilities-205.0-193.0-165.0-220.0—
Cash from Operating Activities
Profit Before Tax (per I/S)-624.0-420.0-16.0238.0463.0
+ Total Adjustments (incl. Working Capital)788.0669.0-37.0173.0—
Cash from Operations (pre-tax)164.0249.0-53.0411.0—
+ Income Taxes Paid11.030.0-31.021.0—
Cash from Operating Activities153.0219.0-22.0390.0—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)42.059.094.0136.0—
+ Disp of Fixed Assets79.066.010.050.0—
+ Acq of Intangibles under Development0.00.0271.0228.0—
+ Disp of Intangibles under Development-167.0-157.00.00.0—
+ Acq of Investment Property0.00.0404.0-39.0—
+ Interest Received — Investing2.03.016.05.0—
+ Other Inflows / (Outflows) — Investing3.010.0-40.029.0—
Cash from Investing Activities-125.0-137.0-783.0-241.0—
Cash from Financing Activities
+ Proceeds from Issue of Shares-3.0467.0982.00.0—
+ Proceeds from Borrowings409.0549.0728.0737.0—
+ Repayment of Borrowings406.0406.01,067.0525.0—
+ Payment of Lease Liabilities73.079.070.071.0—
+ Other Inflows / (Outflows) — Financing-242.0-197.0-164.0-195.0—
Cash from Financing Activities-315.0334.0409.0-54.0—
Net Changes in Cash (pre-FX)-287.0416.0-396.095.0—
+ Effect of FX Rate Changes on Cash7.0-1.03.010.0—
Net Changes in Cash-280.0415.0-393.0105.0—
Closing Cash90.0505.0———
Reference Items
EBITDA101.039.0393.0652.0772.0
EBITDA Margin %3.811.3913.0519.3321.66
Free Cash Flow (CFO − Capex)111.0160.0-116.0254.0254.0
Free Cash Flow per Basic Share6.859.88-7.1615.6815.68
Price to Free Cash Flow————122.64
Cash Flow to Net Income-0.25-0.460.391.96—
Cash Paid for Taxes11.030.0-31.021.0—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.